Self-assembling peptides as vectors for local drug delivery and tissue engineering applications

Adv Drug Deliv Rev. 2021 Jul:174:387-405. doi: 10.1016/j.addr.2021.04.024. Epub 2021 May 7.

Abstract

Molecular self-assembly has forged a new era in the development of advanced biomaterials for local drug delivery and tissue engineering applications. Given their innate biocompatibility and biodegradability, self-assembling peptides (SAPs) have come in the spotlight of such applications. Short and water-soluble SAP biomaterials associated with enhanced pharmacokinetic (PK) and pharmacodynamic (PD) responses after the topical administration of the therapeutic systems, or improved regenerative potential in tissue engineering applications will be the focus of the current review. SAPs are capable of generating supramolecular structures using a boundless array of building blocks, while peptide engineering is an approach commonly pursued to encompass the desired traits to the end composite biomaterials. These two elements combined, expand the spectrum of SAPs multi-functionality, constituting them potent biomaterials for use in various biomedical applications.

Keywords: 3D scaffolds; Molecular self-assembly; Peptide amphiphiles; Supramolecular biomaterials; Tissue engineering; Topical administration.

Publication types

  • Review

MeSH terms

  • Animals
  • Biocompatible Materials / administration & dosage
  • Biocompatible Materials / chemistry
  • Drug Delivery Systems*
  • Humans
  • Peptides / chemistry*
  • Solubility
  • Tissue Engineering / methods*
  • Tissue Scaffolds / chemistry

Substances

  • Biocompatible Materials
  • Peptides